A pioneering clinical trial is set to investigate the use of cannabidiol (CBD) in people with Parkinson’s-related psychosis. Parkinson’s UK will be partnering with scientists at King’s College London in the first large-scale trial which aims to provide preliminary evidence for the safety and efficacy of CBD to alleviate the symptoms of Parkinson’s-related psychosis, characterised by hallucinations and delusions.
Associate Director, Medical WritingClinical ProfessionalsHertfordshire, UK
- FULL TIME
Supply Chain PlannerClinical ProfessionalsUK, Scotland
- FULL TIME
Key Account Manager/Sales ExcutiveClinical ProfessionalsMerseyside, Manchester, London East, Glasgow, Edinburgh, Bristol, UK, South Yorkshire
- FULL TIME
Finance Analyst – Managed ServicesClinical ProfessionalsBerkshire, UK
An International Life Science Staffing Business
Clinical Professionals is an International pharmaceutical research and development recruitment company, with a focus on job placement in the scientific, pharmacology, clinical development and post approval services. We are dedicated to staffing in the Pharmaceutical, Biotechnology, Devices and CRO industries. Our client portfolio includes global leaders in pharmaceutical development and clinical research, whilst our expertise encompasses a wide remit of life science job sectors, including dedicated teams within clinical research, drug safety and pharmacovigilance jobs, medical communications jobs, QA/QC jobs, regulatory affairs jobs and medical affairs jobs. Clinical Professionals always provides candidates and clients with services of the highest ethical standards.
As a International life science staffing agency, Clinical Professionals offer a unique array of services which include “Pipeline Watch” – our advisory consultation programme which is free for candidates, as well as our “Talent Tracker” service – a tracking database that lets us identify as well as track candidates that matches clients staffing needs in the future.
Clinical Professionals have now been successfully running the Graduate Training Academy for 2 years, which identifies, fully funds and trains the most talented Life Sciences University Graduates within the UK and places them into their first to industry role.
Clinical Professionals provide the candidates and client alike with the consultative approach of a specialist staffing organisation combined with the International coverage of an industry leading supplier. We provide our clients and candidates with unrivalled specialist understanding, knowledge and experience in the staffing needs of the life sciences industry.
Specialist Pharmaceutical Jobs Sectors
Clinical Professionals provide jobs within the Life Science community, being the most effective International online pharmaceutical jobs and careers management company in the pharmaceutical, clinical research, medical device, biotech and health care industries. Each of our consultants are strategically aligned to one of these specialist sectors which means that job seekers are assured they are working with consultants who have in-depth role and job knowledge and are experts at placing individuals in their chosen pharmaceutical job sector. Clinical Professional recruits for various clinical jobs including Pharmacovigilance, Regulatory Affairs, Biometrics, Health Economics, Medical Communication, Scientific and Medical Information.
Committed to improving the lives of patients by connecting talented professionals to the life science industry.
Clinical Professionals are affiliate members of APSCo
Contact us today to find out how we can progress your career to the next level
According to a new analysis that uses market capitalisation as a benchmark, Takeda has recently broken into the list of top 20 publicly traded innovative pharma companies after its $62 billion merger with Shire earlier this year. According to the analysis from GlobalData, Takeda’s market cap grew to $63.4 billion in Q1 this year as
GSK announced results from its PRIMA Phase III trial, in which niraparib was studied as a maintenance therapy in women with first-line ovarian cancer following a response to platinum-based chemotherapy. The data showed that the drug resulted in a 38% reduction in the risk of disease progression or death in the overall population, driven by